205470 — Humasis Co Income Statement

0.000.00%

Last trade - 00:00

HealthcareHighly SpeculativeSmall CapSucker Stock

Annual income statement for Humasis Co, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.

	2019 December 31st	R2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Revenue
Total Revenue	9,151	45,717	321,829	471,273	13,827
Cost of Revenue
Gross Profit	3,941	30,861	210,393	255,902	-36,942
Selling / General / Administrative Expenses
Research And Development
Depreciation and Amortization
Unusual Expense / Income
Total Operating Expenses	10,026	20,359	128,236	261,947	74,422
Operating Profit	-875	25,358	193,593	209,325	-60,595
Gain / Loss on Sale of Assets
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes	-1,226	20,962	196,727	237,557	-62,180
Provision for Income Taxes
Net Income After Taxes	-1,226	20,937	151,205	182,627	-55,424
Net Income Before Extraordinary Items
Net Income	-1,226	20,937	151,205	182,627	-55,424
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Dilution Adjustment
Diluted Net Income	-1,226	20,937	151,205	182,627	-55,424
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS	-11.2	161	1,106	1,428	-314
Dividends per Share